Development of Modified-Release Diclofenac Sodium Capsules Using Blends of Pectin-Clay Multiparticulate Hybrid Systems as Release Retardants

A combination of inorganic and organic hybrid systems is of high research interest as they provide novel hybrid systems for the improvement of existing properties, overcoming limitations of the parent materials, and for the optimization of their controlled release potential. This study sorted to dev...

Full description

Saved in:
Bibliographic Details
Main Authors: Ofosua Adi-Dako, Frederick William Akuffo Owusu, Isaac Yaw Attah, Doris Kumadoh, Prince George Acquah Jnr, Issaka Nelson, Nii Odartey Hutton-Mills, Karen Yaa Yeboaa Obese, Joseph Adusei Sarkodie, Benoit Banga N’guessan, Awo Afi Kwapong, Christina Osei-Asare, Emmanuel Adase, Mary-Ann Archer
Format: Article
Language:English
Published: Wiley 2023-01-01
Series:Journal of Chemistry
Online Access:http://dx.doi.org/10.1155/2023/8384739
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832558458136690688
author Ofosua Adi-Dako
Frederick William Akuffo Owusu
Isaac Yaw Attah
Doris Kumadoh
Prince George Acquah Jnr
Issaka Nelson
Nii Odartey Hutton-Mills
Karen Yaa Yeboaa Obese
Joseph Adusei Sarkodie
Benoit Banga N’guessan
Awo Afi Kwapong
Christina Osei-Asare
Emmanuel Adase
Mary-Ann Archer
author_facet Ofosua Adi-Dako
Frederick William Akuffo Owusu
Isaac Yaw Attah
Doris Kumadoh
Prince George Acquah Jnr
Issaka Nelson
Nii Odartey Hutton-Mills
Karen Yaa Yeboaa Obese
Joseph Adusei Sarkodie
Benoit Banga N’guessan
Awo Afi Kwapong
Christina Osei-Asare
Emmanuel Adase
Mary-Ann Archer
author_sort Ofosua Adi-Dako
collection DOAJ
description A combination of inorganic and organic hybrid systems is of high research interest as they provide novel hybrid systems for the improvement of existing properties, overcoming limitations of the parent materials, and for the optimization of their controlled release potential. This study sorted to develop and pharmaceutically assess the release profile of diclofenac sodium using cocoa pod husk (CPH) blended with different proportions of either talc or bentonite as multiparticulate composite release modifiers. Preformulation investigations of the multiparticulate hybrid systems included pH, swelling index, moisture content, elemental contents, and flow properties. The FTIR was also used to investigate the compatibilities between pectin and bentonite (PB), pectin and talc (PT), and diclofenac and pectin-talc (DPT), as well as diclofenac and pectin-bentonite (DPB). The diclofenac content, uniformity of the weight of capsules, in vitro drug release, and the kinetics and mechanism of release of diclofenac from the hybrid systems were also investigated using mathematical models. The pectin yield was 23.3%, with the water-holding capacities of pectin-talc (PT) and pectin-bentonite (PB) hybrid systems being 6.4% and 5.0%, respectively. The swelling indices of PT and PB were 110.0 and 130.0 in 0.1 M HCL at pH 1.2 and 130.0 and 149.0 in phosphate buffer at pH 6.8, respectively. This system was also found to exhibit excellent flow properties, and there were no diclofenac-excipient interactions. All formulated batches passed the pharmacopoeial and nonpharmacopoeial tests. They also demonstrated controlled release properties via different release kinetics and mechanisms. This study shows that the pectin-talc and pectin-bentonite multiparticulate composites could be used as release modifiers in pharmaceutical preparations.
format Article
id doaj-art-7dfa470bbd7f4f50afc88e60845adafd
institution Kabale University
issn 2090-9071
language English
publishDate 2023-01-01
publisher Wiley
record_format Article
series Journal of Chemistry
spelling doaj-art-7dfa470bbd7f4f50afc88e60845adafd2025-02-03T01:32:19ZengWileyJournal of Chemistry2090-90712023-01-01202310.1155/2023/8384739Development of Modified-Release Diclofenac Sodium Capsules Using Blends of Pectin-Clay Multiparticulate Hybrid Systems as Release RetardantsOfosua Adi-Dako0Frederick William Akuffo Owusu1Isaac Yaw Attah2Doris Kumadoh3Prince George Acquah Jnr4Issaka Nelson5Nii Odartey Hutton-Mills6Karen Yaa Yeboaa Obese7Joseph Adusei Sarkodie8Benoit Banga N’guessan9Awo Afi Kwapong10Christina Osei-Asare11Emmanuel Adase12Mary-Ann Archer13Department of Pharmaceutics and MicrobiologyDepartment of PharmaceuticsDepartment of Pharmaceutical ChemistryDepartment of Pharmaceutics and Quality ControlDepartment of PharmaceuticsDepartment of Pharmaceutics and MicrobiologyDepartment of Pharmaceutics and MicrobiologyDepartment of Pharmaceutics and MicrobiologyDepartment of Pharmacognosy and Herbal MedicineDepartment of Pharmacology and ToxicologyDepartment of Pharmaceutics and MicrobiologyDepartment of Pharmaceutics and MicrobiologyDepartment of ProductionDepartment of PharmaceuticsA combination of inorganic and organic hybrid systems is of high research interest as they provide novel hybrid systems for the improvement of existing properties, overcoming limitations of the parent materials, and for the optimization of their controlled release potential. This study sorted to develop and pharmaceutically assess the release profile of diclofenac sodium using cocoa pod husk (CPH) blended with different proportions of either talc or bentonite as multiparticulate composite release modifiers. Preformulation investigations of the multiparticulate hybrid systems included pH, swelling index, moisture content, elemental contents, and flow properties. The FTIR was also used to investigate the compatibilities between pectin and bentonite (PB), pectin and talc (PT), and diclofenac and pectin-talc (DPT), as well as diclofenac and pectin-bentonite (DPB). The diclofenac content, uniformity of the weight of capsules, in vitro drug release, and the kinetics and mechanism of release of diclofenac from the hybrid systems were also investigated using mathematical models. The pectin yield was 23.3%, with the water-holding capacities of pectin-talc (PT) and pectin-bentonite (PB) hybrid systems being 6.4% and 5.0%, respectively. The swelling indices of PT and PB were 110.0 and 130.0 in 0.1 M HCL at pH 1.2 and 130.0 and 149.0 in phosphate buffer at pH 6.8, respectively. This system was also found to exhibit excellent flow properties, and there were no diclofenac-excipient interactions. All formulated batches passed the pharmacopoeial and nonpharmacopoeial tests. They also demonstrated controlled release properties via different release kinetics and mechanisms. This study shows that the pectin-talc and pectin-bentonite multiparticulate composites could be used as release modifiers in pharmaceutical preparations.http://dx.doi.org/10.1155/2023/8384739
spellingShingle Ofosua Adi-Dako
Frederick William Akuffo Owusu
Isaac Yaw Attah
Doris Kumadoh
Prince George Acquah Jnr
Issaka Nelson
Nii Odartey Hutton-Mills
Karen Yaa Yeboaa Obese
Joseph Adusei Sarkodie
Benoit Banga N’guessan
Awo Afi Kwapong
Christina Osei-Asare
Emmanuel Adase
Mary-Ann Archer
Development of Modified-Release Diclofenac Sodium Capsules Using Blends of Pectin-Clay Multiparticulate Hybrid Systems as Release Retardants
Journal of Chemistry
title Development of Modified-Release Diclofenac Sodium Capsules Using Blends of Pectin-Clay Multiparticulate Hybrid Systems as Release Retardants
title_full Development of Modified-Release Diclofenac Sodium Capsules Using Blends of Pectin-Clay Multiparticulate Hybrid Systems as Release Retardants
title_fullStr Development of Modified-Release Diclofenac Sodium Capsules Using Blends of Pectin-Clay Multiparticulate Hybrid Systems as Release Retardants
title_full_unstemmed Development of Modified-Release Diclofenac Sodium Capsules Using Blends of Pectin-Clay Multiparticulate Hybrid Systems as Release Retardants
title_short Development of Modified-Release Diclofenac Sodium Capsules Using Blends of Pectin-Clay Multiparticulate Hybrid Systems as Release Retardants
title_sort development of modified release diclofenac sodium capsules using blends of pectin clay multiparticulate hybrid systems as release retardants
url http://dx.doi.org/10.1155/2023/8384739
work_keys_str_mv AT ofosuaadidako developmentofmodifiedreleasediclofenacsodiumcapsulesusingblendsofpectinclaymultiparticulatehybridsystemsasreleaseretardants
AT frederickwilliamakuffoowusu developmentofmodifiedreleasediclofenacsodiumcapsulesusingblendsofpectinclaymultiparticulatehybridsystemsasreleaseretardants
AT isaacyawattah developmentofmodifiedreleasediclofenacsodiumcapsulesusingblendsofpectinclaymultiparticulatehybridsystemsasreleaseretardants
AT doriskumadoh developmentofmodifiedreleasediclofenacsodiumcapsulesusingblendsofpectinclaymultiparticulatehybridsystemsasreleaseretardants
AT princegeorgeacquahjnr developmentofmodifiedreleasediclofenacsodiumcapsulesusingblendsofpectinclaymultiparticulatehybridsystemsasreleaseretardants
AT issakanelson developmentofmodifiedreleasediclofenacsodiumcapsulesusingblendsofpectinclaymultiparticulatehybridsystemsasreleaseretardants
AT niiodarteyhuttonmills developmentofmodifiedreleasediclofenacsodiumcapsulesusingblendsofpectinclaymultiparticulatehybridsystemsasreleaseretardants
AT karenyaayeboaaobese developmentofmodifiedreleasediclofenacsodiumcapsulesusingblendsofpectinclaymultiparticulatehybridsystemsasreleaseretardants
AT josephaduseisarkodie developmentofmodifiedreleasediclofenacsodiumcapsulesusingblendsofpectinclaymultiparticulatehybridsystemsasreleaseretardants
AT benoitbanganguessan developmentofmodifiedreleasediclofenacsodiumcapsulesusingblendsofpectinclaymultiparticulatehybridsystemsasreleaseretardants
AT awoafikwapong developmentofmodifiedreleasediclofenacsodiumcapsulesusingblendsofpectinclaymultiparticulatehybridsystemsasreleaseretardants
AT christinaoseiasare developmentofmodifiedreleasediclofenacsodiumcapsulesusingblendsofpectinclaymultiparticulatehybridsystemsasreleaseretardants
AT emmanueladase developmentofmodifiedreleasediclofenacsodiumcapsulesusingblendsofpectinclaymultiparticulatehybridsystemsasreleaseretardants
AT maryannarcher developmentofmodifiedreleasediclofenacsodiumcapsulesusingblendsofpectinclaymultiparticulatehybridsystemsasreleaseretardants